Italia markets open in 1 hour 36 minutes

TEVA Jul 2024 14.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,60000,0000 (0,00%)
In data: 01:42PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente2,6000
Aperto2,6000
Denaro2,0000
Domanda2,2800
Prezzo d'esercizio14,50
Scadenza2024-07-12
Min-Max giorno2,6000 - 2,6000
Contratto - Min-MaxN/D
Volume30
Open Interest1
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.